How to Conduct Effective Generic Drug Clinical Studies

The FDA ensures the safety and efficacy of generic drugs through a rigorous review process. Bioequivalence trials, region-specific regulatory understanding, clinical trials, high-quality manufacturing, FDA’s review and approval, and reducing approval times are components of conducting effective generic drug clinical studies. The process demands understanding the role of the FDA and ensuring the generic product meets the high standards of the brand-name counterparts.